Goldman Sachs
GS
$1090.67
+1.35%
Goldman Sachs Group Inc. is a leading global financial institution operating primarily in the Financial - Capital Markets industry, with core businesses spanning investment banking, global markets trading, asset management, and wealth management. The firm is a dominant market leader, particularly in high-margin advisory services, having been the top global M&A advisor by revenue for the past two decades. The current investor narrative centers on the firm's strategic pivot towards more stable, fee-based businesses like asset and wealth management, which comprised roughly 30% of revenue, and its ability to capitalize on a resurgent capital markets and M&A cycle, as evidenced by recent headlines highlighting a surge in investment banking fees and its role as a lead underwriter for high-profile IPOs like SpaceX.…
GS
Goldman Sachs
$1090.67
Related headlines
Investment Opinion: Should I buy GS Today?
Recommendation: Hold. The stock is a high-quality cyclical play on capital markets, but its explosive 70% rally and premium valuation relative to its own history demand caution, awaiting a better entry point or clearer confirmation of cycle sustainability.
The Hold thesis is supported by four key data points: 1) The stock trades at a forward PE of 16.20x, a premium to its historical trough but reasonable for the sector; 2) Revenue growth remains volatile (Q4 YoY -6.6%), failing to provide a stable foundation for multiple expansion; 3) Profitability is strong (ROE 13.74%), but this is already reflected in the price; and 4) The implied upside to analyst targets is muted given the stock is already near its 52-week high, leaving limited near-term alpha from consensus views.
The two biggest risks are a downturn in the capital markets cycle compressing the PE multiple back towards 10x, and a macroeconomic shock that triggers the -43% downside scenario. This Hold would upgrade to a Buy if the PE multiple compressed below 14x on a market pullback, or if quarterly revenue growth sustainably re-accelerates into positive double-digit territory. It would downgrade to a Sell if the technical uptrend breaks decisively below key support (e.g., the $900 level) on high volume, signaling cycle exhaustion. Relative to its own history and growth profile (PEG 0.61), the stock is fairly valued to slightly overvalued after its massive run.
Sign up to view all
GS 12-Month Price Forecast
Goldman Sachs is a quintessential 'show me' story at current levels. The bullish fundamentals—dominant market share, high margins, and cyclical recovery—are undeniable but appear largely priced in following the stock's massive outperformance. The neutral stance reflects the high probability (50%) of a base-case range-bound trading environment where the company executes well but fails to drive further multiple expansion. The stance would upgrade to bullish on a market pullback that brings the PE below 14x, creating a more attractive risk/reward entry to play the cycle. It would turn bearish if quarterly revenue growth turns negative again or if the technical uptrend definitively breaks, signaling the cycle's end.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Goldman Sachs's 12-month outlook, with a consensus price target around $1417.87 and implied upside of +30.0% versus the current price.
Average Target
$1417.87
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$873 - $1418
Analyst target range
Analyst coverage for Goldman Sachs is extensive among major institutions, with recent ratings from firms like Wells Fargo (Overweight), Barclays (Overweight), RBC Capital (Sector Perform), and Keefe, Bruyette & Woods (Market Perform). The consensus sentiment leans neutral-to-bullish, with a mix of 'Overweight' and 'Market Perform' ratings, and no recent outright sell recommendations. The average analyst revenue estimate for the upcoming period is $69.24 billion, with a wide EPS estimate range from $69.99 to $79.25, averaging $74.66. The wide target price range implied by these estimates signals significant uncertainty and debate among analysts regarding the sustainability of the current investment banking boom, the impact of interest rates on trading revenues, and the success of the firm's strategic shift into asset management. A tight clustering of ratings around 'Hold' and 'Market Perform' suggests cautious optimism but a lack of strong conviction for significant multiple expansion from current levels.
Bulls vs Bears: GS Investment Factors
The evidence currently favors the bull case, driven by powerful technical momentum, a dominant competitive position in a recovering M&A/IPO cycle, and strong underlying profitability. However, the bear case presents substantial and fundamental risks centered on extreme financial volatility and a valuation that prices in near-perfect execution. The single most important tension in the investment debate is whether the current capital markets upcycle—and Goldman's ability to monetize it—is sustainable enough to justify its elevated valuation multiple (PE of 16x) and offset the inherent cyclicality and leverage risks embedded in its model. The resolution of this cycle timing will dictate the stock's direction.
Bullish
- Dominant M&A & IPO Market Position: Goldman Sachs is the top global M&A advisor by revenue for the past two decades and is a lead underwriter for high-profile IPOs like SpaceX. This entrenched leadership provides a structural advantage to capture fees from a resurgent capital markets cycle, as evidenced by a reported 48% surge in Q1 investment banking revenue.
- Strong Profitability & High Margins: The firm maintains robust profitability with a Q4 net margin of 15.33% and a trailing ROE of 13.74%. Its gross margin of 51.71% in the latest quarter reflects the high-margin nature of its advisory and trading businesses, providing significant operating leverage.
- Powerful Technical Momentum: The stock is in a sustained uptrend, up 70.01% over the past year and 35.87% over the last three months, significantly outperforming the SPY. Trading at 97% of its 52-week high ($1098.36) confirms strong bullish momentum and investor conviction.
- Attractive PEG Ratio: With a PEG ratio of 0.61, the stock appears undervalued relative to its earnings growth potential. This suggests the market may not be fully pricing in the sustainability of the current earnings recovery and strategic pivot.
Bearish
- Extreme Revenue & Cash Flow Volatility: Q4 revenue declined 6.6% YoY, and TTM free cash flow is deeply negative at -$47.22 billion, highlighting the inherent cyclicality and working capital intensity of its market-making operations. This makes near-term financial performance highly unpredictable.
- Valuation Near Cycle Highs: The stock trades at a trailing PE of 16.00x, well above its multi-year low of ~8.4x. With the price at $1062.75, just 3.2% below the 52-week high, it leaves little margin for error and is vulnerable to multiple compression if the cycle peaks.
- High Financial Leverage: A debt-to-equity ratio of 4.88 indicates significant balance sheet leverage, which is typical for investment banks but amplifies risks during market downturns or periods of rising funding costs, potentially pressuring net interest margins.
- Macro Sensitivity & High Beta: With a beta of 1.29, the stock is 29% more volatile than the market. It is highly sensitive to interest rate shifts and economic cycles, as seen in recent news where hot jobs data triggered sector rotations, posing a constant threat to its premium valuation.
GS Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a 1-year price change of +70.01%, significantly outperforming the broader market. As of the latest close at $1062.75, the price is trading near the top of its 52-week range, approximately 97% of the way towards its 52-week high of $1098.36, indicating strong momentum but also potential overextension. The recent momentum is exceptionally strong and accelerating, with a 1-month gain of +11.23% and a 3-month surge of +35.87%, both far exceeding the SPY's performance of -0.08% and +12.0% over the same periods, respectively. This short-term acceleration confirms the longer-term bullish trend, with the stock demonstrating significant relative strength, as shown by a 1-month relative strength figure of +11.31. Key technical support is anchored at the 52-week low of $609.59, while immediate resistance sits at the 52-week high of $1098.36. A decisive breakout above this high would signal a continuation of the powerful uptrend, while a failure could lead to consolidation. The stock's beta of 1.29 indicates it is approximately 29% more volatile than the SPY, which is a critical consideration for risk management and position sizing given its recent explosive moves.
Beta
1.29
1.29x market volatility
Max Drawdown
-19.8%
Largest decline past year
52-Week Range
$623-$1098
Price range past year
Annual Return
+73.7%
Cumulative gain past year
| Period | GS Return | S&P 500 |
|---|---|---|
| 1m | +15.0% | +1.5% |
| 3m | +35.4% | +13.4% |
| 6m | +24.5% | +10.9% |
| 1y | +73.7% | +24.5% |
| ytd | +19.3% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
GS Fundamental Analysis
Revenue growth has been volatile but showed a strong sequential recovery in the most recent quarter, with Q4 2025 revenue of $30.13 billion representing a -6.6% year-over-year decline but a significant improvement from the prior quarter's trend. Segment data indicates the Global Markets division, with $20.63 billion in revenue, is the primary revenue driver, while Investment Management contributed $9.22 billion. The firm is highly profitable, with Q4 2025 net income of $4.62 billion and a net margin of 15.33%. Profitability metrics have been robust, with a trailing twelve-month Return on Equity (ROE) of 13.74% and a gross margin for the quarter of 51.71%, reflecting the high-margin nature of its advisory and trading businesses. The balance sheet is leveraged, as is typical for a major investment bank, with a debt-to-equity ratio of 4.88. Financial health is supported by a strong Return on Assets (ROA) of 0.94% but is complicated by cash flow volatility; the latest quarterly free cash flow was deeply negative at -$16.81 billion, and the TTM free cash flow is -$47.22 billion, largely due to significant working capital movements and investment activities inherent to its market-making operations, rather than operational distress.
Quarterly Revenue
$30.1B
2025-12
Revenue YoY Growth
-0.06%
YoY Comparison
Gross Margin
+0.51%
Latest Quarter
Free Cash Flow
$-47.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is GS Overvalued?
Given the positive net income of $4.62 billion in the latest quarter, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 16.00x and a forward PE of 16.20x, based on estimated EPS. The negligible gap between trailing and forward multiples suggests the market has already priced in steady earnings expectations for the near term. Compared to sector averages, the valuation appears reasonable; for instance, its Price-to-Sales (PS) ratio of 2.20x and Price-to-Book (PB) ratio of 2.20x are standard for a high-quality capital markets firm. The PEG ratio of 0.61, based on trailing metrics, suggests the stock may be undervalued relative to its growth profile if that growth is sustained. Historically, the current trailing PE of 16.00x sits above the multi-year low seen in late 2023 (around 8.4x) but is well below the euphoric highs above 20x seen during peak earnings cycles in 2021-2022. This positioning indicates the market is valuing the stock with optimism for the current cycle but not at peak historical exuberance.
PE
16.0x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 4x~23x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
30.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. The firm's revenue is highly volatile, with Q4 showing a -6.6% YoY decline, and profitability is heavily dependent on the capital markets cycle. A debt-to-equity ratio of 4.88 signifies high leverage, which could strain the balance sheet in a downturn. Most concerning is the deeply negative TTM free cash flow of -$47.22 billion, which, while partly operational for a market-maker, underscores significant cash consumption and reliance on favorable funding markets. Earnings visibility is low, as evidenced by the wide dispersion in analyst EPS estimates.
Market & Competitive Risks are elevated due to valuation and macro sensitivity. Trading at a trailing PE of 16.00x, well above its cycle low, the stock is vulnerable to multiple compression if growth expectations falter. Its beta of 1.29 confirms high market correlation, making it a likely casualty in risk-off environments, as seen in recent rotations triggered by inflation fears. While its competitive moat in advisory is strong, the entire investment banking sector faces disruption from private markets and direct listings. Regulatory risks, including annual stress tests, also loom, though recent news suggests a temporary freeze on capital buffers.
The Worst-Case Scenario involves a sharp reversal of the capital markets cycle combined with a macroeconomic slowdown. This would trigger a simultaneous decline in M&A fees, trading revenues, and asset management fees, while rising funding costs compress net interest income. Leverage would amplify losses. In this adverse scenario, the stock could realistically re-test its 52-week low of $609.59, representing a potential downside of approximately -43% from the current price of $1062.75. A drawdown to the analyst low EPS scenario could also imply a similar magnitude of decline, highlighting the asymmetric risk following its massive 70% one-year rally.
FAQ
The key risks, in order of severity, are: 1) Cyclicality Risk: Revenue and earnings are highly volatile and tied to capital markets activity (Q4 revenue -6.6% YoY). 2) Valuation & Leverage Risk: A high PE of 16x after a 70% rally and a debt-to-equity ratio of 4.88 amplify downside in a downturn. 3) Macro Sensitivity: With a beta of 1.29, the stock is highly correlated to interest rates and economic sentiment, making it vulnerable to inflation shocks and sector rotations. 4) Execution Risk: The strategic pivot to asset management (30% of revenue) must continue to gain traction to offset core business volatility.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $1000 and $1150 as the current cycle persists. The Bull Case (30% probability) targets $1150-$1250 on an acceleration of the IPO/M&A boom. The Bear Case (20% probability) warns of a drop to $700-$900 if the cycle reverses sharply. The most likely outcome is the Base Case, which assumes the company meets current earnings expectations but struggles to expand its valuation multiple further from today's elevated level.
GS appears fairly valued to slightly overvalued relative to its own history. It trades at a trailing PE of 16.00x, which is reasonable for a quality financial firm but is well above its multi-year low of ~8.4x and leaves little room for error. The PEG ratio of 0.61 suggests undervaluation relative to growth, but this hinges on volatile earnings growth being sustained. The market is currently pricing in a continuation of the favorable capital markets cycle and successful execution of the firm's strategic pivot. A downturn would quickly reveal the stock as overvalued.
GS is a Hold, not a compelling buy at the current price of $1062.75. While the company's fundamentals are strong and it is a leader in a recovering cycle, the stock has already rallied 70% in one year and trades near its 52-week high, leaving limited near-term upside and significant downside risk (up to -43% to its 52-week low). It could be a good buy for aggressive, cycle-aware investors on a meaningful pullback that brings the PE multiple below 14x, offering a better risk/reward profile to capitalize on the ongoing capital markets upswing.
GS is more suitable for medium-term, tactical investment aligned with the capital markets cycle (1-3 years) rather than as a buy-and-hold-forever stock. Its high beta (1.29) and cyclical earnings profile create too much volatility for a stable long-term core holding, and its dividend yield (1.9%) is not sufficient for income investors. Given the current stage of the cycle, investors should have a minimum horizon of 12-18 months to ride through potential volatility, but be prepared to reduce exposure if clear signs of a cycle peak emerge.
